服用方法:每日2片,大量凉开水送服推荐年龄:6岁以上人群重要提示:不含乳糖·不含酵母·不含糖份·不含麸质·不含防腐剂芬兰原装进口营养专家推荐搭配:维他美乐北欧多种浆果浓缩咀嚼片NO.5617 ~调整新陈代谢,补充身体所需多种营养 FloraGLO® LUTEIN叶黄素是人体的“天然墨镜”,时刻保护着眼睛的视网膜。因此摄入充足的FloraGLO® LUTEIN叶黄素和玉米黄质,是预防这些眼睛疾病并延缓眼睛衰老中非常重要的一环。 FloraGLO® Lutein叶黄素拥有哪些专利? 美国US Patent:5,382,714 ;5,648,564;6,663,900 日本JP Patent:2,790,212;3,190,686 澳大利亚AU Patent:700,719 新西兰NZ Patent:332,280 德国DE Patent:69,516,031 墨西哥MX Patent:205,122 以色列IL Patent:124,987 欧盟十四国(芬兰FI,德国DE,希腊GR,法国FR,比利时BE,英国UK,荷兰NL,瑞典SE,奥地利AT,爱尔兰IE,葡萄牙PT,意大利IT,丹麦DK,卢森堡LU):0672655 ;0,904,258 参考文献:References: 1. Lutein and zeaxanthin and the risk of cataract: the Melbourne visual impairment project. Vu HT, et al. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3783-6. 2. Lutein and Zeaxanthin - Monograph. Altern Med Rev. 2005 Jun;10(2):128-135. 3. Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation. Bhosale P et al. Biochim Biophys Acta. 2005 May 30;1740(2):116-21 4. Diet and serum carotenoid concentrations affect macular pigment optical density in adults 45 years and older. Burke JD, Curran-Celentano J, Wenzel AJ. J Nutr. 2005 May;135(5):1208-14. 5. Dietary lutein and zeaxanthin: possible effects on visual function. Stringham JM, Hammond BR Jr. Nutr Rev. 2005 Feb;63(2):59-64. 6. Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr Rev. 2005 Jan;63(1):9-15. Johnson EJ. 7. Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Beatty S, Nolan J, Kavanagh H, O'Donovan O. Arch Biochem Biophys. 2004 Oct 1;430(1):70-6. 8. The science behind lutein. Alves-Rodrigues A, Shao A. Toxicol Lett. 2004 Apr 15;150(1):57-83. 9. Olmedilla B, Granado F, Blanco I, Vaquero M. Lutein, but not alpha-tocopherol, supplementation improves visual function in patients with age-related cataracts: a 2-y double-blind, placebo-controlled pilot study. Nutrition 2003 Jan;19(1):21-4 10. Krinsky NI. Possible biologic mechanisms for a protective role of xanthophylls. J Nutr 2002 Mar;132(3):540S-542S 11. Mares-Perlman JA, Millen AE, Ficek TL, Hankinson SE. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. J Nutr 2002 Mar;132(3):518S-524S 12. Beatty S, Murray IJ, Henson DB, Carden D, Koh HH, Boulton ME Macular Pigment and Risk for Age-Related Macular Degeneration in Subjects from a Northern European Population. Invest Ophthalmol Vis Sci 2001 Feb;42(2):439-446 13. Dagnelie G, Zorge IS, McDonald TM Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry 2000 Mar;71(3):147-64 14. Johnson EJ, Hammond BR, Yeum KJ, Qin J, Wang XD, Castaneda C, Snodderly DM, Russell RM Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 2000 Jun;71(6):1555-1562 15. Rapp LM, Maple SS, Choi JH Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci 2000 Apr;41(5):1200-9